FDA Science Board Advisory Committee Meeting

November 6, 2003

5630 Fishers Lane, Room 1066

 

AGENDA

 

8:00 a.m.         Call to Order

Michael P. Doyle, Ph.D., Chair, FDA Science Board

 

8:15 a.m.         Welcome and opening remarks

Mark B. McClellan, M.D., Ph.D., Commissioner of Food & Drugs 

 

8:45 a.m.         Overview of the FDA Food Security Program

                                Joseph A. Levitt, Esq., Director, Center for Food Safety and Applied Nutrition, FDA

 

9:15 a.m.         Break

 

9:30 a.m.         Threat/Vulnerability Assessments

                                Robert Brackett, Ph.D., Director, Food Safety and Security Staff, Center for Food Safety and Applied Nutrition, FDA

 

10:00 a.m.       Food Security Research Needs, Priorities, Resources, and Challenges

Robert L. Buchanan, Ph.D., Director, Office of Science, Center for Food Safety and Applied Nutrition, FDA

 

10:30 a.m.       Prevention Research

                                David J. Armstrong, Ph.D., National Center for Food Safety and Technology Associate  Research Director, Office of Plant & Dairy Foods & Beverages, Center for Food Safety and Applied Nutrition, FDA

 

11:00 a.m.       Food Security Research at the National Center for Toxicological Research

Daniel A. Casciano, Ph.D., Director, National Center for Toxicological Research, FDA

 

11:30 a.m.            Questions and Discussion with the Board/Presenters

 

12:00 p.m.       Lunch

 

1:00 p.m.         Open Public Comment

 

2:00 p.m.         Animal Feed Safety System (AFSS), BSE and Food Security Research at the Center for Veterinary Medicine

Linda Youngman, MS, Ph.D., Director, Office of Research, Center for Veterinary Medicine, FDA

 

2:30 p.m.         Food Emergency Response Network (FERN)

Carl Sciacchitano, Senior Microbiologist, Division of Field Programs, Office of Regulatory Affairs, FDA

 

3:00 p.m.         Facilitating Biologics Product Development to Address Threats to Food Security

Jesse L. Goodman, M.D., M.P.H., Director, Center for Biologics Evaluation & Research, FDA

 

3:30 p.m.         Medical Counter Measures

                                Dianne Murphy, M.D., Director, Office of Counter Terrorism and Pediatric Drug Development, Center for Drug Evaluation & Research, FDA

 

3:45 p.m.         Questions and Discussion with the Board/Presenters

 

4:30 p.m.         Closing Remarks - Recommendations